Placebo response: in studies on pain and under other clinical conditions (Q33938286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692009%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

review article

1 reference

title

Placebo response: in studies on pain and under other clinical conditions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692009%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692009%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

B Horing

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692009%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

S Klosterhalfen

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692009%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

P Enck

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692009%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

German

0 references

publication date

1 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692009%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692009%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692009%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692009%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

325-335

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21692009%20AND%20SRC:MED&resulttype=core&format=json

Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Placebo versus best-available-therapy control group in clinical trials for pharmacologic therapies: which is better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Overt versus covert treatment for pain, anxiety, and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Unbalanced randomization influences placebo response: scientific versus ethical issues around the use of placebo in migraine trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

New insights into the placebo and nocebo responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

The placebo response in functional dyspepsia--reanalysis of trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Frequency and circumstances of placebo use in clinical practice--a systematic review of empirical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Biological, clinical, and ethical advances of placebo effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Discrete coding of reward probability and uncertainty by dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Meta-analysis: factors affecting placebo response rate in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Quantification of the placebo response in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Deception in research on the placebo effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Estimating drug effects in the presence of placebo response: causal inference using growth mixture modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

The placebo effect in irritable bowel syndrome trials: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

A prefrontal non-opioid mechanism in placebo analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Declaration of Helsinki, 2008: implications for stakeholders in research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Individual differences in reward responding explain placebo-induced expectations and effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Predictors of the placebo response in functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00482-010-1012-1

Double-blind versus deceptive administration of a placebo

21 January 2018

1 reference

12 December 2020

[Waiting time for and length of physicianc's consultation define the patient-physician interaction: results of a prospective study in 478 patients with chronic viral hepatitis]

1 reference

12 December 2020

Separate mechanisms for placebo and opiate analgesia?

1 reference

12 December 2020

International ethical regulations on placebo-use in clinical trials: a comparative analysis.

1 reference

12 December 2020

Superiority, equivalence, and non-inferiority trials

1 reference

12 December 2020

Are drug and placebo effects in depression additive?

1 reference

12 December 2020

Moderators of placebo response to antipsychotic treatment in patients with schizophrenia: a meta-regression

1 reference

12 December 2020

Suspended judgment. Memories of the British Streptomycin Trial in Tuberculosis. The first randomized clinical trial

1 reference

12 December 2020

Therapy options in irritable bowel syndrome

1 reference

12 December 2020